Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on May 18, 2009

Hypertension. 2009
Published online before print May 18, 2009, doi: 10.1161/HYPERTENSIONAHA.109.133710
A more recent version of this article appeared on July 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
54/1/142    most recent
HYPERTENSIONAHA.109.133710v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briones, A. M.
Right arrow Articles by Salaices, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briones, A. M.
Right arrow Articles by Salaices, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ATORVASTATIN
*HEPTANOIC ACID
*MALONALDEHYDE
*PYRROLE
Related Collections
Right arrow Remodeling
Right arrow Cardiovascular Pharmacology
Right arrow Hypertension - basic studies
Right arrow Peripheral vascular disease
Right arrow Other Vascular biology

Submitted on March 29, 2009
Revised on April 14, 2009

Atorvastatin Prevents Angiotensin II–Induced Vascular Remodeling and Oxidative Stress

Ana M. Briones*; Natalia Rodríguez-Criado; Raquel Hernanz; Ana B. García-Redondo; Raul R. Rodrigues-Díez; María J. Alonso; Jesús Egido; Marta Ruiz-Ortega; and Mercedes Salaices

From the Departmento de Farmacología, Facultad de Medicina (A.M.B., N.R.-C., R.H., A.B.G.-R., M.S.), and Laboratorio de Investigación Vascular y Renal (R.R.R.-D., J.E., M.R.-O.), Fundación Jiménez Díaz, Universidad Autónoma de Madrid; and the Departmento de Ciencias de la Salud III (R.H., M.J.A.), Universidad Rey Juan Carlos, Madrid, Spain.

* To whom correspondence should be addressed. E-mail: ana.briones{at}uam.es.

Abstract—Angiotensin II (Ang II) modulates vasomotor tone, cell growth, and extracellular matrix deposition. This study analyzed the effect of atorvastatin in the possible alterations induced by Ang II on structure and mechanics of mesenteric resistance arteries and the signaling mechanisms involved. Wistar rats were infused with Ang II (100 ng/kg per day, SC minipumps, 2 weeks) with or without atorvastatin (5 mg/kg per day). Ang II increased blood pressure and plasmatic malondialdehyde levels. Compared with controls, mesenteric resistance arteries from Ang II–treated rats showed the following: (1) decreased lumen diameter; (2) increased wall/lumen; (3) decreased number of adventitial, smooth muscle, and endothelial cells; (4) increased stiffness; (5) increased collagen deposition; and (6) diminished fenestrae area and number in the internal elastic lamina. Atorvastatin did not alter blood pressure but reversed all of the structural and mechanical alterations of mesenteric arteries, including collagen and elastin alterations. In mesenteric resistance arteries, Ang II increased vascular O2·- production and diminished endothelial NO synthase and CuZn/superoxide dismutase but did not modify extracellular-superoxide dismutase expression. Atorvastatin improved plasmatic and vascular oxidative stress, normalized endothelial NO synthase and CuZn/superoxide dismutase expression, and increased extracellular-superoxide dismutase expression, showing antioxidant properties. Atorvastatin also diminished extracellular signal–regulated kinase 1/2 activation caused by Ang II in these vessels, indicating an interaction with Ang II–induced intracellular responses. In vascular smooth muscle cells, collagen type I release mediated by Ang II was reduced by different antioxidants and statins. Moreover, atorvastatin downregulated the Ang II–induced NADPH oxidase subunit, Nox1, expression. Our results suggest that statins might exert beneficial effects on hypertension-induced vascular remodeling by improving vascular structure, extracellular matrix alterations, and vascular stiffness. These effects might be mediated by their antioxidant properties.


Key words: angiotensin II • atorvastatin • extracellular matrix • remodeling • oxidative stress